CD151 immunoreactivity at diagnosis predicts early biochemical failure and metastasis in prostate cancer

被引：0
|
作者：
Vasquez, Catalina [1 ]
Martinez, Carlos [1 ]
Chan, Susanne [2 ]
Chalasani, Venu [1 ]
Gomez-Lemus, Jose [2 ]
Williams, Andrew [1 ]
Chin, Joseph [3 ]
Zijlstra, Andries [4 ]
Lewis, John [1 ]
机构：
[1] Univ Western Ontario, Translat Prostate Canc Res Grp, London, ON, Canada
[2] Univ Western Ontario, Dept Pathol, Translat Prostate Canc Res Grp, London, ON, Canada
[3] Univ Western Ontario, Dept Oncol, London Hlth Sci Ctr, Translat Prostate Canc Res Grp, London, ON, Canada
[4] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN USA
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2011-2260
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2260
引用
收藏
页数：1
相关论文
共 50 条
  • [1] CD151 and cell motility in prostate cancer
    Detchokul, Sujitra
    Parker, Michael W.
    Williams, Elizabeth D.
    Herdiman, Olivia M.
    Davis, Melissa
    Kee, Kelvin
    Bolton, Damien M.
    Frauman, Albert G.
    CANCER RESEARCH, 2012, 72
  • [2] CD151 in cancer progression and metastasis: a complex scenario
    Sadej, Rafal
    Grudowska, Alicja
    Turczyk, Lukasz
    Kordek, Radzislaw
    Romanska, Hanna M.
    LABORATORY INVESTIGATION, 2014, 94 (01) : 41 - 51
  • [3] CD151 and prostate cancer progression: A review of current literature
    Kang, Zhen
    Luo, Yanping
    Xiao, Enhua
    Li, Qiubai
    Wang, Liang
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 (04) : 434 - 438
  • [4] The role of CD151 as a clinical prognostic marker in prostate cancer
    Newell, B.
    Williams, E.
    Opeskin, K.
    Bolton, D.
    Frauman, A.
    BJU INTERNATIONAL, 2007, 99 : 6 - 6
  • [5] CD151 expression in prostate cancer metastases: a potential target?
    Newell, B.
    Detchokul, S.
    Williams, E.
    Bolton, D.
    Frauman, A.
    BJU INTERNATIONAL, 2009, 103 : 38 - 38
  • [6] Overexpression of CD151 Predicts Prognosis in Patients with Resected Gastric Cancer
    Yang, Yue-Ming
    Zhang, Zhong-Wei
    Liu, Qing-Meng
    Sun, Yi-Feng
    Yu, Ji-Ren
    Xu, Wei-Xing
    PLOS ONE, 2013, 8 (03):
  • [7] CD151 is associated with prostate cancer cell invasion and lymphangiogenesis in vivo
    Detchokul, Sujitra
    Newell, Bradley
    Williams, Elizabeth D.
    Frauman, Albert G.
    ONCOLOGY REPORTS, 2014, 31 (01) : 241 - 247
  • [8] Integrin-associated CD151 is a suppressor of prostate cancer progression
    Han, Rongbo
    Hensley, Patrick J.
    Li, Jieming
    Zhang, Yang
    Stark, Timothy W.
    Heller, Allie
    Qian, Hai
    Shi, Junfeng
    Liu, Zeyi
    Huang, Jian-An
    Jin, Tengchuan
    Wei, Xiaowei
    Zhou, Binhua P.
    Wu, Yadi
    Kyprianou, Natasha
    Chen, Jinfei
    Yang, Xiuwei H.
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2020, 12 (04): : 1428 - 1442
  • [9] Regulation of CD151 by Hypoxia Controls Cell Adhesion and Metastasis in Colorectal Cancer
    Chien, Chun-Wei
    Lin, Shih-Chieh
    Lai, Yen-Yu
    Lin, Bo-Wen
    Lin, Shao-Chieh
    Lee, Jenq-Chang
    Tsai, Shaw-Jenq
    CLINICAL CANCER RESEARCH, 2008, 14 (24) : 8043 - 8051
  • [10] PROSTATE CANCER HYPOXIA PREDICTS EARLY BIOCHEMICAL FAILURE AFTER RADIOTHERAPY
    Milosevic, M.
    Bristow, R.
    Chung, P.
    Warde, P.
    Catton, C.
    Menard, C.
    Hill, R.
    RADIOTHERAPY AND ONCOLOGY, 2009, 92 : S11 - S12
12345